80
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation

, , , , , , , , & show all
Pages 1421-1426 | Published online: 28 Nov 2013

References

  • Borel JF History of the discovery of cyclosporin and of its early pharmacological development Wien Klin Wochenschr 2002 114 12 433 437 12422576
  • Pollard S Nashan B Johnston A CONSENT: Consensus on Substitution in European Transplantation A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001 Clin Ther 2003 25 6 1654 1669 12860490
  • Vítko S Ferkl M Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial Kidney Int Suppl 2010 115 S12 S16 20150905
  • Niemczyk M Paczek L Generic formulation of Cyclosporine A, Equoral®, in de novo kidney transplant recipients: five-year follow-up Ann Transplant 2011 16 2 59 62 21716187
  • Billingham M Kobashigawa JA The revised ISHLT heart biopsy grading scale J Heart Lung Transplant 2005 24 11 1709 16297769
  • Karapirli M Kizilgun M Yesilyurt O Simultaneous determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in whole-blood samples by LC-MS/MS Scientific World Journal 2012 2012 571201 22629148
  • Perlik F Masri MA Rost M Kamarád V Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005 149 2 309 313 16601778
  • Maziers N Bulpa P Jamart J Delaunois L Eucher P Evrard P Correlations between cyclosporine concentrations at 2 hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients Transplant Proc 2012 44 9 2880 2884 23146546
  • Helderman JH Kang N Legorreta AP Chen JY Healthcare costs in renal transplant recipients using branded versus generic ciclosporin Appl Health Econ Health Policy 2010 8 1 61 68 20038194
  • Knight SR Morris PJ The clinical benefits of cyclosporine C2-level monitoring: a systematic review Transplantation 2007 83 12 1525 1535 17589331
  • Harrison JJ Schiff JR Coursol CJ Generic immunosuppression in solid organ transplantation: a Canadian perspective Transplantation 2012 93 7 657 665 22267158